Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
NCT01336569
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Travoprost 0.004%/timolol maleate 0.5% fixed combination
Sponsor
Alcon Research